Does Ezetimibe Effectiveness Vary by Age?
Ezetimibe lowers LDL cholesterol by blocking intestinal absorption, working across adult age groups from trials like IMPROVE-IT (ages 50+) and SEAS (ages 45+), where it reduced cardiovascular events regardless of specific age subsets.[1] No head-to-head data shows one adult age group responds better; efficacy ties more to baseline cholesterol and statin use than age alone.[2]
How Well Does It Work in Adults Over 65?
People 65+ often see similar or slightly greater LDL reductions (15-25% added to statins) due to higher comorbidity rates, per post-hoc analyses of trials like ENHANCE.[3] FDA approves it for ages 10+ without upper limits, and real-world studies confirm consistent benefits in octogenarians when tolerated.[1][4]
Can Kids Under 10 Take Ezetimibe?
FDA approval starts at age 10 for homozygous familial hypercholesterolemia (HoFH); no data supports use below that due to lack of trials. In 10-17-year-olds with HeFH, it cuts LDL by 20%+ alongside diet, matching adult responses.[1][5]
What About Use in People Over 75?
Trials like IMPROVE-IT included up to age 86, showing hazard ratios for events around 0.85-0.90 favoring ezetimibe/statin combos, with no efficacy drop-off.[2] Frailty or polypharmacy may limit tolerability more than effectiveness.
Why No Clear 'Best' Age Group?
Age-stratified meta-analyses find no statistical superiority; differences stem from trial demographics (mostly 50-70) rather than biology. Pediatric approval reflects safety data, not superior response.[3][6]
[1]: FDA Label for Zetia (ezetimibe)
[2]: IMPROVE-IT Trial, NEJM 2015
[3]: Cannon et al., JACC 2015 (age subgroup analysis)
[4]: DrugPatentWatch.com - Ezetimibe Patent Status (includes trial summaries)
[5]: Guttmacher et al., Pediatrics 2019 (pediatric review)
[6]: Kanaki et al., Meta-analysis Atherosclerosis 2020